 | • レポートコード：QYR2104Z1825 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（インスリン、経口血糖降下薬、非インスリン注射薬）、用途別市場規模（病院、個人、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病治療の市場動向 ・企業の競争状況、市場シェア ・糖尿病治療の種類別市場規模（インスリン、経口血糖降下薬、非インスリン注射薬） ・糖尿病治療の用途別市場規模（病院、個人、クリニック、その他） ・糖尿病治療の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novo Nordisk、AstraZeneca、Teva Pharmaceuticals、Merck＆Company、Medtronic、Johnson＆Johnson、Sanofi、GlaxoSmithKline、Abbott Laboratories、Benemae、Eli Lilly、Boehringer Ingelheim） ・結論 |
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved people’s living habits, disease control effect, is becoming more and more important.
Market Analysis and Insights: Global Diabetes Treatment Market
The global Diabetes Treatment market size is projected to reach US$ 54030 million by 2026, from US$ 42040 million in 2019, at a CAGR of 3.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Treatment market.
Global Diabetes Treatment Scope and Market Size
Diabetes Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Insulin
Oral Hypoglycaemic Drugs
Non-Insulin Injectable Drugs
Segment by Application
Hospital
Personal Use
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novo Nordisk
AstraZeneca
Teva Pharmaceuticals
Merck＆Company
Medtronic
Johnson＆Johnson
Sanofi
GlaxoSmithKline
Abbott Laboratories
Merck＆Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Insulin
1.2.3 Oral Hypoglycaemic Drugs
1.2.4 Non-Insulin Injectable Drugs
1.3 Market by Application
1.3.1 Global Diabetes Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Personal Use
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Treatment Market Perspective (2016-2027)
2.2 Diabetes Treatment Growth Trends by Regions
2.2.1 Diabetes Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Treatment Industry Dynamic
2.3.1 Diabetes Treatment Market Trends
2.3.2 Diabetes Treatment Market Drivers
2.3.3 Diabetes Treatment Market Challenges
2.3.4 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Treatment Players by Revenue
3.1.1 Global Top Diabetes Treatment Players by Revenue (2016-2021)
3.1.2 Global Diabetes Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Treatment Revenue
3.4 Global Diabetes Treatment Market Concentration Ratio
3.4.1 Global Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Treatment Revenue in 2020
3.5 Diabetes Treatment Key Players Head office and Area Served
3.6 Key Players Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Treatment Breakdown Data by Type
4.1 Global Diabetes Treatment Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Treatment Forecasted Market Size by Type (2022-2027)
5 Diabetes Treatment Breakdown Data by Application
5.1 Global Diabetes Treatment Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetes Treatment Market Size (2016-2027)
6.2 North America Diabetes Treatment Market Size by Type
6.2.1 North America Diabetes Treatment Market Size by Type (2016-2021)
6.2.2 North America Diabetes Treatment Market Size by Type (2022-2027)
6.2.3 North America Diabetes Treatment Market Size by Type (2016-2027)
6.3 North America Diabetes Treatment Market Size by Application
6.3.1 North America Diabetes Treatment Market Size by Application (2016-2021)
6.3.2 North America Diabetes Treatment Market Size by Application (2022-2027)
6.3.3 North America Diabetes Treatment Market Size by Application (2016-2027)
6.4 North America Diabetes Treatment Market Size by Country
6.4.1 North America Diabetes Treatment Market Size by Country (2016-2021)
6.4.2 North America Diabetes Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetes Treatment Market Size (2016-2027)
7.2 Europe Diabetes Treatment Market Size by Type
7.2.1 Europe Diabetes Treatment Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Treatment Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Treatment Market Size by Type (2016-2027)
7.3 Europe Diabetes Treatment Market Size by Application
7.3.1 Europe Diabetes Treatment Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Treatment Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Treatment Market Size by Application (2016-2027)
7.4 Europe Diabetes Treatment Market Size by Country
7.4.1 Europe Diabetes Treatment Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Treatment Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetes Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Treatment Market Size by Application
8.3.1 Asia-Pacific Diabetes Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetes Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Treatment Market Size (2016-2027)
9.2 Latin America Diabetes Treatment Market Size by Type
9.2.1 Latin America Diabetes Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Treatment Market Size by Type (2016-2027)
9.3 Latin America Diabetes Treatment Market Size by Application
9.3.1 Latin America Diabetes Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Treatment Market Size by Application (2016-2027)
9.4 Latin America Diabetes Treatment Market Size by Country
9.4.1 Latin America Diabetes Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Treatment Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetes Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Treatment Market Size by Application
10.3.1 Middle East & Africa Diabetes Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetes Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Treatment Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Treatment Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Diabetes Treatment Introduction
11.2.4 AstraZeneca Revenue in Diabetes Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Teva Pharmaceuticals
11.3.1 Teva Pharmaceuticals Company Details
11.3.2 Teva Pharmaceuticals Business Overview
11.3.3 Teva Pharmaceuticals Diabetes Treatment Introduction
11.3.4 Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2016-2021)
11.3.5 Teva Pharmaceuticals Recent Development
11.4 Merck＆Company
11.4.1 Merck＆Company Company Details
11.4.2 Merck＆Company Business Overview
11.4.3 Merck＆Company Diabetes Treatment Introduction
11.4.4 Merck＆Company Revenue in Diabetes Treatment Business (2016-2021)
11.4.5 Merck＆Company Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Diabetes Treatment Introduction
11.5.4 Medtronic Revenue in Diabetes Treatment Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Johnson＆Johnson
11.6.1 Johnson＆Johnson Company Details
11.6.2 Johnson＆Johnson Business Overview
11.6.3 Johnson＆Johnson Diabetes Treatment Introduction
11.6.4 Johnson＆Johnson Revenue in Diabetes Treatment Business (2016-2021)
11.6.5 Johnson＆Johnson Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Diabetes Treatment Introduction
11.7.4 Sanofi Revenue in Diabetes Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Diabetes Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Diabetes Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Diabetes Treatment Introduction
11.9.4 Abbott Laboratories Revenue in Diabetes Treatment Business (2016-2021)
11.9.5 Abbott Laboratories Recent Development
11.10 Benemae
11.10.1 Benemae Company Details
11.10.2 Benemae Business Overview
11.10.3 Benemae Diabetes Treatment Introduction
11.10.4 Benemae Revenue in Diabetes Treatment Business (2016-2021)
11.10.5 Benemae Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Diabetes Treatment Introduction
11.11.4 Eli Lilly Revenue in Diabetes Treatment Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Details
11.12.2 Boehringer Ingelheim Business Overview
11.12.3 Boehringer Ingelheim Diabetes Treatment Introduction
11.12.4 Boehringer Ingelheim Revenue in Diabetes Treatment Business (2016-2021)
11.12.5 Boehringer Ingelheim Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetes Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Insulin
Table 3. Key Players of Oral Hypoglycaemic Drugs
Table 4. Key Players of Non-Insulin Injectable Drugs
Table 5. Global Diabetes Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetes Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetes Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diabetes Treatment Market Share by Regions (2016-2021)
Table 9. Global Diabetes Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diabetes Treatment Market Share by Regions (2022-2027)
Table 11. Diabetes Treatment Market Trends
Table 12. Diabetes Treatment Market Drivers
Table 13. Diabetes Treatment Market Challenges
Table 14. Diabetes Treatment Market Restraints
Table 15. Global Diabetes Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diabetes Treatment Market Share by Players (2016-2021)
Table 17. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment as of 2020)
Table 18. Ranking of Global Top Diabetes Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diabetes Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetes Treatment Product Solution and Service
Table 22. Date of Enter into Diabetes Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diabetes Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Diabetes Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diabetes Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diabetes Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diabetes Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Diabetes Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diabetes Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetes Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diabetes Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novo Nordisk Company Details
Table 63. Novo Nordisk Business Overview
Table 64. Novo Nordisk Diabetes Treatment Product
Table 65. Novo Nordisk Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 66. Novo Nordisk Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Diabetes Treatment Product
Table 70. AstraZeneca Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Teva Pharmaceuticals Company Details
Table 73. Teva Pharmaceuticals Business Overview
Table 74. Teva Pharmaceuticals Diabetes Treatment Product
Table 75. Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 76. Teva Pharmaceuticals Recent Development
Table 77. Merck＆Company Company Details
Table 78. Merck＆Company Business Overview
Table 79. Merck＆Company Diabetes Treatment Product
Table 80. Merck＆Company Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 81. Merck＆Company Recent Development
Table 82. Medtronic Company Details
Table 83. Medtronic Business Overview
Table 84. Medtronic Diabetes Treatment Product
Table 85. Medtronic Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 86. Medtronic Recent Development
Table 87. Johnson＆Johnson Company Details
Table 88. Johnson＆Johnson Business Overview
Table 89. Johnson＆Johnson Diabetes Treatment Product
Table 90. Johnson＆Johnson Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 91. Johnson＆Johnson Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Diabetes Treatment Product
Table 95. Sanofi Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Abbott Laboratories Company Details
Table 102. Abbott Laboratories Business Overview
Table 103. Abbott Laboratories Diabetes Treatment Product
Table 104. Abbott Laboratories Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 105. Abbott Laboratories Recent Development
Table 106. Benemae Company Details
Table 107. Benemae Business Overview
Table 108. Benemae Diabetes Treatment Product
Table 109. Benemae Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 110. Benemae Recent Development
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Diabetes Treatment Product
Table 114. Eli Lilly Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 115. Eli Lilly Recent Development
Table 116. Boehringer Ingelheim Company Details
Table 117. Boehringer Ingelheim Business Overview
Table 118. Boehringer Ingelheim Diabetes Treatment Product
Table 119. Boehringer Ingelheim Revenue in Diabetes Treatment Business (2016-2021) & (US$ Million)
Table 120. Boehringer Ingelheim Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Treatment Market Share by Type: 2020 VS 2027
Figure 2. Insulin Features
Figure 3. Oral Hypoglycaemic Drugs Features
Figure 4. Non-Insulin Injectable Drugs Features
Figure 5. Global Diabetes Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Personal Use Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Diabetes Treatment Report Years Considered
Figure 11. Global Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Diabetes Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Diabetes Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Diabetes Treatment Market Share by Regions (2022-2027)
Figure 15. Global Diabetes Treatment Market Share by Players in 2020
Figure 16. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Treatment Revenue in 2020
Figure 18. Global Diabetes Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Diabetes Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Diabetes Treatment Market Share by Type (2016-2027)
Figure 22. North America Diabetes Treatment Market Share by Application (2016-2027)
Figure 23. North America Diabetes Treatment Market Share by Country (2016-2027)
Figure 24. United States Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetes Treatment Market Share by Type (2016-2027)
Figure 28. Europe Diabetes Treatment Market Share by Application (2016-2027)
Figure 29. Europe Diabetes Treatment Market Share by Country (2016-2027)
Figure 30. Germany Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetes Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Diabetes Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Diabetes Treatment Market Share by Region (2016-2027)
Figure 40. China Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetes Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Diabetes Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Diabetes Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetes Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Diabetes Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Diabetes Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novo Nordisk Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 62. Merck＆Company Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 63. Medtronic Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 64. Johnson＆Johnson Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 67. Abbott Laboratories Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 68. Benemae Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 70. Boehringer Ingelheim Revenue Growth Rate in Diabetes Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially ey…- 世界の不適切管理2型糖尿病治療市場規模・現状・予測（2021年-2027年） Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different …
- 世界の糖尿病治療装置・薬剤市場規模・現状・予測（2021年-2027年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- 世界の糖尿病用非インスリン療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 54930 million by 2026, from US$ 30040 million in 2019, at a CAGR of 8.9% during 2021-2026. With industry-standard accuracy in analysis an…
- 世界の糖尿病用非インスリン療法市場 2021：企業別、地域別、種類・用途別 The Non-Insulin Therapies for Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…